The event brings together more than 600 industry stakeholders in an uncommonly candid day-long discussion of how the industry is changing and how we position ourselves to succeed, followed by an evening celebration of our work’s impact on health.
The 2025 Symposium will focus on technologies and approaches poised to shape our markets, with the key theme of multidimensional ruggedness and adaptability in the face of uncertainty. We live in changing times — with technological pace, geopolitical risk, and economic pressure converging to create an increasingly intricate path to navigate. Resilience requires insight; and efficiency requires the strength of a deep, diverse community. We invite you to join us at the Symposium to be an active participant in this open discussion.
In the evening of March 6, we host our Annual Medtech Impact Gala. The Gala is an exclusive evening event that not only celebrates the impact medical technology makes on patients’ lives but elevates the patient voice.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.